Bristows' Podcast

Team-NB, representing the majority of Notified Bodies for EU MDR and IVDR medical devices, has issued a stark warning: the implementation of the EU AI Act carries a significant risk of major disruption to the medical device software sector. Their recently published Position Paper doesn't hold back, highlighting critical shortcomings in the implementation framework and emphasising the dwindlin...

In the second episode of our series exploring Corporate Law and AI, our experts, Partner Iain Redford (Corporate & Tax) and Partner Vik Khurana (Commercial Technology), highlight some of the key risks which are likely to arise in doing deals with the next generation of AI companies with suggestions about ways to mitigate those risks. Find all the episodes as we release them here , and don’t fo...

In the first episode of our series exploring Corporate Law and AI, our experts, Partner Vik Khurana (Commercial Technology) and Of Counsel Richard Swaine (Corporate & Tax), focused on the current state of AI transactional work and recognising and protecting value. Find all the episodes as we release them here , and don’t forget to subscribe! Note: All information was correct at the time of rec...

Following the CJEU’s landmark decision in the BSH v Electrolux case (C-339/22), patent litigators Andrew Bowler and Gregory Bacon discuss the three questions referred by the Swedish Court of Appeal to the European court. Explore our more detailed analysis here Note : All information was correct at the time of recording.

It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our editors, Greg Bacon , Xisca Borrás , and Will Hewitt , thought now would be a great time to catch up and discuss any developments since the launch. You can also find written updates on the following articles here : Integrating generative AI into the life scien...

In this episode our experts Iain Redford (corporate), Miranda Cass (tax) and Gareth Wadley (employment and global mobility) set out the key considerations and potential pitfalls involved in Acquihire deals - an increasing trend we see from across the Atlantic as strategic buyers and institutions look to acquire the best talent and technology to drive innovation. Find all the episodes as we release...

In this episode of Tech M&A, our experts, Jamie Drucker and Richard Swaine look at the regulatory challenges facing Adtech companies and consider how commercial and legal diligence - and approach to transaction risk - in Adtech M&A may have to refocus in the light of those challenges.  Find all the episodes as we release them here , and don’t forget to subscribe! Note: All information was...

In this episode of Tech M&A, our experts, Sophie Rees and Jamie Hatzel discuss some of the recent trends affecting medtech M&A, in particular recent regulatory changes which are affecting the evolution of the sector. They also discuss some of the M&A pitfalls which have arisen out of those trends – and how focussed due diligence can help investors avoid them. Find all the episodes as w...

Chris Bates and Vivien Zhu introduce the UK government’s consultation on a statutory regime for disclosure of transfers of value to the healthcare sector by the life sciences industry. Chris talks about the historical context of voluntary schemes for disclosures of transfers of value, while Vivien introduces the data protection implications of such disclosures. The Statutory Disclosure Regime cons...

Jamie Hatzel and Vivien Zhu delve into some of the finer details of the Statutory Disclosure Regime proposals, including the scope of the proposed regime and the role that voluntary disclosure schemes could continue to play once the regime comes into force. Vivien also talks through how the Statutory Disclosure Regime should prompt some companies to consider whether their data protection arrangeme...

Chris Bates and Jamie Hatzel round out this three-part series with a discussion of the likely impact of the Statutory Disclosure Regime proposals on the medtech sector, and how medtech will have to play catch-up to remain compliant once the Statutory Disclosure Regime comes into force.  The Statutory Disclosure Regime consultation closes on 16 October 2023. To learn more and submit a response, see...

In this episode, experts Chris Devlin and Julia Cockroft explore the impact the National Security and Investment Act 2021 has had on transactions involving companies active in AI. The conversation then moves onto the valuable R&D tax reliefs that might be available to businesses harnessing the power of AI and how those reliefs should be taken into account as part of deal negotiations. Find all...

In this episode, Luke Maunder discusses the long-awaited FRAND judgment of Mr Justice Mellor with special guest star Dr Myles Jelf. Luke and Myles delve into the decision and set out the key information you need to know. 

In this quick update, senior associates and IP specialists Luke Maunder and Naomi Hazenberg  discuss the recent decision in Kigen v Thales, which considers the jurisdiction of the court for a claim that included FRAND declarations that were free-standing and/or tied to declarations of invalidity and non-essentiality.

Senior associates and IP specialists Luke Maunder and Naomi Hazenberg discuss the development of the English FRAND injunction and the timing of when an undertaking to enter a FRAND licence is required. 

Senior associates and IP specialists Luke Maunder and Naomi Hazenberg go back to the future to look at FRAND methodologies before the British Courts. They begin by looking at what was done in the seminal Unwired Planet case, before moving on to the detail of the unresolved issues including those that are up for consideration in the cases of InterDigital v Lenovo and Optis v Apple . For the true ec...

Senior associates and IP specialists, Luke Maunder and Naomi Hazenberg ,  look at how the British Courts have treated patent pools, before delving into some of the issues they present in litigation. They also cover suggestions that the principle of pool licensing could apply on the other side of the fence, looking at licensing negotiation groups and approaches that seek to achieve a similar object...

"If only we could have a little more transparency" is a refrain heard by every licensor, but commercial sensitivities and confidentiality obligations/concerns abound in the FRAND space. Senior associates and IP specialists, Luke Maunder and Naomi Hazenberg ,  look at how the British Courts have sought to balance the right to information on comparable licences (and associated information)...

Senior associates and IP specialists Luke Maunder and Naomi Hazenberg briefly recap the history of jurisdiction challenges in the British Courts, including the relevant aspects of the decision by the UK Supreme Court in Conversant / Unwired Planet . They then look in detail at the latest decision of the Court of Appeal in Nokia v Oppo , when Oppo attempted to have the FRAND aspects stayed in favou...

Associates Rob Powell and Jamie Witton explore the phenomenon of virtual voice assistance (VVA). They discuss the uses of this type of software and some of the positives, as well as sharing a few horror stories along the way which highlight some of the data security concerns to think about. What potential data breach scenarios could data subjects face?   As technology continues to expand, will reg...